We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ben Venue Consent Decree Could Be Signal on Hospira, Analyst Says
Ben Venue Consent Decree Could Be Signal on Hospira, Analyst Says
January 23, 2013
Boehringer Ingelheim subsidiary Ben Venue Laboratories has signed a consent decree to resolve a history of good manufacturing practice (GMP) slipups.